HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electrophysiological features of Hirayama disease.

AbstractINTRODUCTION:
The purpose of this study was to compare the pattern of hand muscle involvement in Hirayama disease (HD) and amyotrophic lateral sclerosis (ALS).
METHODS:
We reviewed findings of upper limb nerve conduction studies of 46 HD patients and 60 ALS patients. The findings from 54 healthy subjects were used for comparison.
RESULTS:
In HD, the ulnar compound muscle action potential (CMAP) amplitude was more severely reduced than the median one, and the reverse pattern was observed in ALS. The mean ulnar/median (U/M) CMAP amplitude ratio was significantly lower in HD (0.64 ± 0.79) and abnormally higher in ALS (2.15 ± 1.77) compared with normal subjects (0.89 ± 0.23). An abnormally low U/M CMAP amplitude ratio (<0.6) was encountered in 34 patients with HD and in 1 with ALS. A U/M CMAP amplitude ratio ≥4.5 or absent median motor response was found only in ALS.
CONCLUSION:
Our findings demonstrate different patterns of hand muscle involvement between these two diseases.
AuthorsRong-Kuo Lyu, Ying-Chih Huang, Yih-Ru Wu, Hung-Chou Kuo, Long-Sun Ro, Chiung-Mei Chen, Hong-Shiu Chang
JournalMuscle & nerve (Muscle Nerve) Vol. 44 Issue 2 Pg. 185-90 (Aug 2011) ISSN: 1097-4598 [Electronic] United States
PMID21755506 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Wiley Periodicals, Inc.
Topics
  • Action Potentials (physiology)
  • Adolescent
  • Adult
  • Aged
  • Amyotrophic Lateral Sclerosis (physiopathology)
  • Child
  • Electric Stimulation
  • Evoked Potentials, Motor (physiology)
  • Female
  • Hand (innervation, physiopathology)
  • Humans
  • Male
  • Median Nerve (physiopathology)
  • Middle Aged
  • Muscle, Skeletal (innervation, physiopathology)
  • Neural Conduction (physiology)
  • Retrospective Studies
  • Spinal Muscular Atrophies of Childhood (physiopathology)
  • Ulnar Nerve (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: